TAYLOR CLIVE R 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Sep 17, 2003
Insider Transaction Report
Form 4
TAYLOR CLIVE R
Director
Transactions
- Exercise/Conversion
Common Stock
2003-09-15$0.34/sh+7,100$2,414→ 26,100 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-09-15$1.80/sh−7,100$12,780→ 1,774,900 totalExercise: $0.34From: 2001-12-22Exp: 2009-12-22→ Common Stock (7,100 underlying) - Sale
Common Stock
2003-09-16$1.80/sh−16,100$28,980→ 19,000 total - Sale
Common Stock
2003-09-15$1.80/sh−7,100$12,780→ 19,000 total - Exercise/Conversion
Common Stock
2003-09-16$0.34/sh+16,100$5,474→ 35,100 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-09-16$1.80/sh−16,100$28,980→ 1,758,800 totalExercise: $0.34From: 2001-12-22Exp: 2009-12-22→ Common Stock (16,100 underlying)